Cancer Center Advances Research Program with New Pathology Expertise
Recruited scientists specializing in genomics, metabolics and basic research join the Center
|Stony Brook Cancer Center research pathologists, pictured in front, from left: John Haley, PhD, and Geoffrey Girnun, PhD. In back: Patricia Thompson, PhD, and Scott Powers, PhD.|
Stony Brook, NY, January 9, 2015 – Four faculty recruited by the Department of Pathology at Stony Brook University School of Medicine within the past year bring additional expertise to the Stony Brook University Cancer Center research program to help advance the development of new and more effective targeted therapeutics for cancer.
“Cancer is a complicated disease process, and a better understanding of all forms of cancer at the tissue and molecular levels will drive our diagnostic and therapeutic processes,” said Yusuf A. Hannun, MD, Director of the Stony Brook University Cancer Center, Vice Dean for Cancer Medicine, and the Joel Kenny Professor of Medicine. “These new faculty from the Department of Pathology will be leaders for our growing basic and translational research endeavors.”
“By recruiting an outstanding and diverse core of Pathology faculty, we will continue to build on the strengths of our already well-established cancer research faculty in 2015, as well as bring the department to the forefront of basic and translational cancer research at the national level,” added Kenneth R. Shroyer, MD, PhD, the Marvin Kuschner Professor and Chair of Pathology.
John Haley, PhD, a molecular endocrinologist, joined the Department of Pathology as Associate Professor and was appointed Director of Cancer Development Therapeutics for the Cancer Center. Dr. Haley, who holds numerous patents and has authored more than 60 manuscripts related to the development of novel therapeutics, will spearhead Cancer Center programs evaluating cancer biomarkers, cancer drug resistance, and new drug development.
Patricia Thompson, PhD, a nationally recognized researcher focusing on the discovery and validation of biomarkers to identify individuals at greatest risk for cancer recurrence, joined Stony Brook as a Professor of Pathology and Associate Director for Basic Research in the Cancer Center. The Principal Investigator for several research grants from the National Cancer Institute (NCI), Dr. Thompson also brings her nationally prominent research program that is focused on the evolution of molecular and cellular changes that occur during the development of colorectal and breast cancer.
Scott Powers, PhD, Professor of Pathology and a scientist who has devoted much of his career to advancing the field of genomics in cancer research, spearheads genetic investigations of cancer as the Director of Clinical Cancer Genomics at the Cancer Center. A former director of the Human Genome Center at Cold Spring Harbor Laboratory, Dr. Powers’ research on properties involving breast, ovarian, and prostate cancer and adenocarcinomas has received continuous funding from the NCI and other Federal agencies for his research.
Geoffrey Girnun, PhD, Associate Professor of Pathology, and Director of Cancer Metabolomics at the Cancer Center, investigates the metabolic control of liver cancer and molecular co-activation in obesity and colon cancer. An expert in free radicals and cancer biology, Dr. Girnun will continue his research at Stony Brook and collaborate with other Cancer Center faculty to explore the role of metabolics and cancer development.